A Tale of Two Afflictions: Transverse Myelitis and COVID-19 in a Young Female Patient
- PMID: 38916003
- PMCID: PMC11195912
- DOI: 10.7759/cureus.61066
A Tale of Two Afflictions: Transverse Myelitis and COVID-19 in a Young Female Patient
Abstract
Acute transverse myelitis (ATM) is a syndrome of multiple etiologies, with acute or subacute onset in which inflammation of the spinal cord results in neurological deficits, including weakness, sensory loss, and autonomic dysfunction. It is often associated with infectious or autoimmune etiologies but can be considered idiopathic when extensive workup is negative. We present a case of a young African American female who presented with acute onset of bilateral lower extremity weakness, loss of sensation, and autonomic dysfunction. On physical exam, she had absent lower extremity reflexes, 0-1/5 power, and markedly diminished sensation with no pain/temperature discrimination with an abdominal sensory level at T4. There was no upper extremity involvement. She was incidentally found to be COVID-19-positive and denied ever being vaccinated in the past. MRI of the spine revealed diffuse signal abnormality within the cervical and thoracic spine extending to the conus, and an MRI of the brain showed two white matter lesions in the frontal lobes. Lumbar puncture showed lymphocytic pleocytosis and elevated protein; Gram stain did not reveal any pathogen. The patient was treated initially with high doses of steroids with minimal response. She underwent multiple sessions of plasmapheresis with good tolerance and response. Differential diagnoses considered for this case were Guillain Barre syndrome, neuromyelitis optica (NMO), multiple sclerosis, SLE-induced transverse myelitis, or infectious cases. All lab work and workup came back negative for these diseases, leaving us with an interesting culprit: COVID-19 associated. There have been few cases mentioned in the literature of transverse myelitis caused by COVID-19, and this remains a possibility, as all other causes were ruled out.
Keywords: acute transverse myelitis (atm); covid 19; covid 19 encephalitis; neuromyelitis optica spectrum disorder; viral transverse myelitis.
Copyright © 2024, Castellanos et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




References
-
- Transverse myelitis. Borchers AT, Gershwin ME. Autoimmun Rev. 2012;11:231–248. - PubMed
-
- Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis. Jarius S, Aktas O, Ayzenberg I, et al. https://doi.org/10.1007/s00415-023-11634-0. J Neurol. 2023;270:3341–3368. - PMC - PubMed
-
- Acute transverse myelitis in COVID-19 infection. Chow CC, Magnussen J, Ip J, Su Y. https://casereports.bmj.com/content/13/8/e236720.citation-tools BMJ Case Rep. 2020;13:0–236720. - PMC - PubMed
-
- Transverse myelitis related to COVID-19 infection. Zachariadis A, Tulbu A, Strambo D, Dumoulin A, Di Virgilio G. https://link.springer.com/article/10.1007/s00415-020-09997-9. J Neurol. 2020;267:3459–3461. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous